BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 22528913)

  • 21. Chemoembolization for hepatocellular carcinoma: epinephrine followed by a doxorubicin-ethiodized oil emulsion and gelatin sponge powder.
    Clouse ME; Stokes KR; Kruskal JB; Perry LJ; Stuart KE; Nasser IA
    J Vasc Interv Radiol; 1993; 4(6):717-25. PubMed ID: 7506597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Computed tomographic perfusion imaging for the therapeutic response of chemoembolization for hepatocellular carcinoma.
    Yang L; Zhang XM; Tan BX; Liu M; Dong GL; Zhai ZH
    J Comput Assist Tomogr; 2012; 36(2):226-30. PubMed ID: 22446364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of viable tumor in hepatocellular carcinoma treated with transcatheter arterial chemoembolization: usefulness of attenuation value measurement at quadruple-phase helical computed tomography.
    Kim SH; Lee WJ; Lim HK; Lim JH
    J Comput Assist Tomogr; 2007; 31(2):198-203. PubMed ID: 17414753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of transcatheter intraarterial perfusion MR imaging and fluorescent microsphere perfusion measurements during transcatheter arterial embolization of rabbit liver tumors.
    Virmani S; Wang D; Harris KR; Ryu RK; Sato KT; Lewandowski RJ; Nemcek AA; Szolc-Kowalska B; Woloschak G; Salem R; Larson AC; Omary RA
    J Vasc Interv Radiol; 2007 Oct; 18(10):1280-6. PubMed ID: 17911519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The value of paradoxical uptake of hepatocellular carcinoma on the hepatobiliary phase of gadoxetic acid-enhanced liver magnetic resonance imaging for the prediction of lipiodol uptake after transcatheter arterial chemoembolization.
    Kim JW; Lee CH; Park YS; Seo TS; Song MG; Kim JH; Kim KA; Park CM
    Eur J Radiol; 2017 Apr; 89():169-176. PubMed ID: 28267535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Previous chemoembolization response after transcatheter arterial chemoembolization (TACE) can predict the anti-tumor effect of subsequent TACE with miriplatin in patients with recurrent hepatocellular carcinoma.
    Imai N; Ikeda K; Seko Y; Kawamura Y; Sezaki H; Hosaka T; Akuta N; Kobayashi M; Saitoh S; Suzuki F; Suzuki Y; Arase Y; Kumada H
    Oncology; 2011; 80(3-4):188-94. PubMed ID: 21709428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Transcatheter arterial chemoembolization with doxorubicin eluting beads in the treatment of hepatocellular carcinoma].
    Sousa PF; Preto AS; Leão D; Madureira AM; Paquete J; Costa-Maia J; Vilares-Morgado P
    Acta Med Port; 2011; 24(1):29-36. PubMed ID: 21672439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transarterial Chemoembolization of Hepatocellular Carcinoma Using Radiopaque Drug-Eluting Embolics: How to Pursue Periprocedural Cross-Sectional Imaging?
    Ruff C; Grözinger G; Syha R; Elser S; Partovi S; Bitzer M; Horger M; Nikolaou K; Grosse U
    J Vasc Interv Radiol; 2019 Mar; 30(3):380-389.e4. PubMed ID: 30819480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
    Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
    Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcatheter arterial chemoembolization with fine-powder cisplatin-lipiodol for HCC.
    Koizumi Y; Hirooka M; Uehara T; Kisaka Y; Uesugi K; Kumagi T; Abe M; Matsuura B; Hiasa Y; Onji M
    Hepatogastroenterology; 2011; 58(106):512-5. PubMed ID: 21661422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application of DC beads in hepatocellular carcinoma: clinical and radiological results of a drug delivery device for transcatheter superselective arterial embolization.
    Sadick M; Haas S; Loehr M; Elshwi M; Singer MV; Brade J; Schoenberg SO; Diehl SJ
    Onkologie; 2010; 33(1-2):31-7. PubMed ID: 20164659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of Existing Response Criteria in Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization Using a 3D Quantitative Approach.
    Tacher V; Lin M; Duran R; Yarmohammadi H; Lee H; Chapiro J; Chao M; Wang Z; Frangakis C; Sohn JH; Maltenfort MG; Pawlik T; Geschwind JF
    Radiology; 2016 Jan; 278(1):275-84. PubMed ID: 26131913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transcatheter arterial chemoembolization (TACE) in treatment of hepatocellular carcinoma.
    Barone M; Ettorre GC; Ladisa R; Schiavariello M; Santoro C; Francioso G; Vinciguerra V; Francavilla A
    Hepatogastroenterology; 2003; 50(49):183-7. PubMed ID: 12630019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of emulsion containing Gd-DTPA and lipiodol in hepatic transcatheter arterial embolization.
    Shiono T; Yoshikawa K; Hisamatsu K; Takenaka E
    Radiat Med; 1993; 11(5):187-90. PubMed ID: 8290693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcatheter arterial chemoembolization of hepatocellular carcinoma: a Japanese experience.
    Higashihara H; Okazaki M
    Hepatogastroenterology; 2002; 49(43):72-8. PubMed ID: 11941988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Change in Perfusion Angiography During Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma Predicts Short-Term Outcomes.
    Kim HO; Yim NY; Kim JK; Kang YJ; Lee BC; Kim JW
    AJR Am J Roentgenol; 2019 Oct; 213(4):746-754. PubMed ID: 31039020
    [No Abstract]   [Full Text] [Related]  

  • 37. Transcatheter arterial chemoembolization therapy combined with percutaneous ethanol injection for unresectable large hepatocellular carcinoma: an evaluation of the local therapeutic effect and survival rate.
    Dohmen K; Shirahama M; Shigematsu H; Miyamoto Y; Torii Y; Irie K; Ishibashi H
    Hepatogastroenterology; 2001; 48(41):1409-15. PubMed ID: 11677976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pseudolesion of the liver on gadoxetate disodium-enhanced MR images obtained after transarterial chemoembolization for hepatocellular carcinoma: clinicoradiologic correlation.
    Shinagawa Y; Sakamoto K; Fujimitsu R; Shimakura M; Kora S; Takano K; Yoshimitsu K
    AJR Am J Roentgenol; 2012 Nov; 199(5):1010-7. PubMed ID: 23096173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcatheter arterial infusion chemotherapy with a fine-powder formulation of cisplatin for advanced hepatocellular carcinoma refractory to transcatheter arterial chemoembolization.
    Iwasa S; Ikeda M; Okusaka T; Ueno H; Morizane C; Nakachi K; Mitsunaga S; Kondo S; Hagihara A; Shimizu S; Satake M; Arai Y
    Jpn J Clin Oncol; 2011 Jun; 41(6):770-5. PubMed ID: 21459893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of tumor necrosis of hepatocellular carcinoma after chemoembolization: diffusion-weighted and contrast-enhanced MRI with histopathologic correlation of the explanted liver.
    Mannelli L; Kim S; Hajdu CH; Babb JS; Clark TW; Taouli B
    AJR Am J Roentgenol; 2009 Oct; 193(4):1044-52. PubMed ID: 19770328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.